Michael M. Schwartz

A Fungal Immunotherapeutic Vaccine (NDV-3A) for Treatment of Recurrent Vulvovaginal Candidiasis—A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial

John E. Edwards, Michael M. Schwartz, Clint S. Schmidt et al. · Clinical Infectious Diseases · 2018 · 205 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +16

Capping Ligands as Selectivity Switchers in Hydrogenation Reactions

Soon Gu Kwon, Galyna Krylova, Aslıhan Sümer et al. · Nano Letters · 2012 · 165 citations

Natural Sciences, Chemistry, Materials Science +17

Safety, immunogenicity, and efficacy of NDV-3A against Staphylococcus aureus colonization: A phase 2 vaccine trial among US Army Infantry trainees

Eugene V. Millar, Jason W. Bennett, Burc Barin et al. · Vaccine · 2021 · 19 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

HDS and deep HDS activity of CoMoS-mesostructured clay catalysts

Kathleen A. Carrado, J. H. Kim, Chunshan Song et al. · Catalysis Today · 2006 · 16 citations

Natural Sciences, Chemistry, Materials Science +14